DiscoverA Health PodysseyInside U.S. Generic Drug Approvals: Risk, Regulation & Policy w/ Jennifer Kao
Inside U.S. Generic Drug Approvals: Risk, Regulation & Policy w/ Jennifer Kao

Inside U.S. Generic Drug Approvals: Risk, Regulation & Policy w/ Jennifer Kao

Update: 2025-10-28
Share

Description

Subscribe to UnitedHealthcare's Community & State newsletter.


In this episode, Rob Lott interviews Jennifer Kao of the UCLA Anderson School of Management in front of a live audience about her paper in the October 2025 issue of Health Affairs exploring the impact of risk evaluation and mitigation strategies on generic approvals of US pharmaceutical products.


Order the October 2025 issue of Health Affairs.

Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcast



Subscribe to UnitedHealthcare's Community & State newsletter.

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Inside U.S. Generic Drug Approvals: Risk, Regulation & Policy w/ Jennifer Kao

Inside U.S. Generic Drug Approvals: Risk, Regulation & Policy w/ Jennifer Kao

Health Affairs